About BridgeBio Pharma, Inc.

BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs from early discovery to late‑stage clinical trials across precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments worldwide.

What You’ll Do

The legal work behind bringing medicines to patients is rarely one‑dimensional. It spans commercial contracting, launch readiness, promotional review, digital channels, compliance, privacy, and the judgment to know when to move quickly and when to pause. As Legal Counsel, International, you will support pre‑launch activities, comme...